药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxymetazoline
Cortisone acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Hydroxychloroquine.
Oxymetazoline
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Hydroxychloroquine.
Oxymetazoline
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Hydroxychloroquine.
Oxymetazoline
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Hydroxychloroquine.
Oxymetazoline
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Hydroxychloroquine.
Oxymetazoline
Ifosfamide
The risk or severity of adverse effects can be increased when Ifosfamide is combined with Hydroxychloroquine.
Oxymetazoline
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Hydroxychloroquine.
Oxymetazoline
Trilostane
The risk or severity of adverse effects can be increased when Trilostane is combined with Hydroxychloroquine.
Oxymetazoline
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Hydroxychloroquine.
Oxymetazoline
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Hydroxychloroquine.
Oxymetazoline
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Hydroxychloroquine.
Oxymetazoline
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Hydroxychloroquine.
Oxymetazoline
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Hydroxychloroquine.
Oxymetazoline
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Hydroxychloroquine.
Maprotiline
Dalfampridine
The risk or severity of seizure can be increased when Valganciclovir is combined with Dalfampridine.
Maprotiline
Amifampridine
The risk or severity of seizure can be increased when Valganciclovir is combined with Amifampridine.
Maprotiline
Cenobamate
The therapeutic efficacy of Cenobamate can be decreased when used in combination with Valganciclovir.
Maprotiline
JNJ-26489112
The therapeutic efficacy of JNJ-26489112 can be decreased when used in combination with Valganciclovir.
Maprotiline
Eslicarbazepine
The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Valganciclovir.
Maprotiline
Cannabidivarin
The therapeutic efficacy of Cannabidivarin can be decreased when used in combination with Valganciclovir.